| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/23/2006 | US7049296 For therapy and prophylaxis of Alzheimer's disease |
| 05/23/2006 | US7049084 Neuroblastoma cell lines expressing the α2δ subunit of calcium channels and methods therefore |
| 05/23/2006 | US7048954 Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 05/23/2006 | US7048934 Combined regulation of neural cell production |
| 05/23/2006 | US7048909 Aerosols containing nondegraded atenolol, pindolol, esmolol, propranolol, or metoprolol |
| 05/23/2006 | US7048906 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 05/23/2006 | CA2291134C Method for the preparation of citalopram |
| 05/23/2006 | CA2263921C Oral delayed immediate release formulation and method of preparation therefor |
| 05/23/2006 | CA2232141C Substituted tetracyclic tetrahydrofuran derivatives |
| 05/23/2006 | CA2188841C Use of 2-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene for the prophylaxis and treatment of the sequelae of acute and chronic reduced cerebral blood supply and neurodegenerative disorders |
| 05/18/2006 | WO2006053217A1 Weight loss composition and method |
| 05/18/2006 | WO2006053109A1 Heteroaryl compounds |
| 05/18/2006 | WO2006052887A1 Formulations of [1,4]diazepino[6,7,1-ij]quinoline derivatives |
| 05/18/2006 | WO2006052378A1 Constrained compounds as cgrp-receptor antagonists |
| 05/18/2006 | WO2006052190A1 Indazole sulphonamide derivatives |
| 05/18/2006 | WO2006052189A1 Nitro indazole derivatives |
| 05/18/2006 | WO2006051997A1 Cystein dioxygenase inducer |
| 05/18/2006 | WO2006051826A1 Nitrogenous heterocyclic compound and pharmaceutical use thereof |
| 05/18/2006 | WO2006051797A1 Therapeutic agent for interstitial cystitis |
| 05/18/2006 | WO2006051773A1 Agent for recovery from cerebral fatigue |
| 05/18/2006 | WO2006051704A1 Imine compound |
| 05/18/2006 | WO2006051489A1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases |
| 05/18/2006 | WO2006051476A1 Tricyclic guanidine derivatives as sodium-proton exchange inhibitors |
| 05/18/2006 | WO2006051413A1 Azabenoxazoles for the treatment of cns disorders |
| 05/18/2006 | WO2006051410A1 Azabenzoxazoles for the treatment of cns disorders |
| 05/18/2006 | WO2006051407A1 Azabenzoxazoles for the treatment of cns disorders |
| 05/18/2006 | WO2006051394A1 Azabenzoxazoles for the treatment of cns disorders |
| 05/18/2006 | WO2006051378A1 Substituted n-sulfonylaminobenzyl-2-phenoxy acetamide compounds |
| 05/18/2006 | WO2006051341A1 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands |
| 05/18/2006 | WO2006051154A1 Treatment of restless legs syndrome |
| 05/18/2006 | WO2006050992A1 Compounds having activity at nk3 receptor and uses thereof in medicine |
| 05/18/2006 | WO2006050991A1 Compounds having activity at nk3 receptor and uses thereof in medicine |
| 05/18/2006 | WO2006050989A1 Compounds having activity at nk3 receptor and uses thereof in medicine |
| 05/18/2006 | WO2006050667A1 MONOCLONAL ANTIBODIES AGAINST APOPTOSIS-RELATED ACETYLCHOLINESTERASE (AR-AChE) AND USE THEREOF |
| 05/18/2006 | WO2006038006A3 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of cns disorders |
| 05/18/2006 | WO2006033000A3 N-ethyl hydroxyethylamine useful in treating cns conditions |
| 05/18/2006 | WO2005115346A9 Pharmaceutical composition containing risperidone |
| 05/18/2006 | WO2004014306A3 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/18/2006 | US20060106224 Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazoles from cyclohexanes and cyclohexanones as intermediates |
| 05/18/2006 | US20060106222 Aminoadamantane derivatives as therapeutic agents |
| 05/18/2006 | US20060106220 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 05/18/2006 | US20060106202 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 05/18/2006 | US20060106114 Tertiary amino compounds having opioid receptor affinity |
| 05/18/2006 | US20060106111 Phenylnaphthalene compounds |
| 05/18/2006 | US20060106108 Method for scavenging radicals with urocanic acid, derivatives and analogues |
| 05/18/2006 | US20060106102 Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif) |
| 05/18/2006 | US20060106096 6-[(Anilinocarbonyl)amino]-N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-1-benzothiophene-2-carboxamide hydrochloride; treatment of dementia, attention deficit hyperactivity disorder and impairments of learning and memory |
| 05/18/2006 | US20060106082 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation |
| 05/18/2006 | US20060106069 4-(5-Chloro-2-isopropylaminopyridin-4-yl)-1-(toluene-4-sulfonyl)-1H-pyrrole-2-carboxylic acid methyl ester; mitogen-activated protein kinase inhibitor; antiproliferative, anticarcinogenic agent; study of intracellular signal transduction pathways; evaluation of new kinase inhibitors |
| 05/18/2006 | US20060106054 Phosphodiesterase 10a inhibitors |
| 05/18/2006 | US20060106048 Furoisoquinoline derivative and use thereof |
| 05/18/2006 | US20060106046 2-(3,4-difluorophenyl)-N-methyl-2-(1H-1,2,3-triazol-1-yl)-N-[3-(spiro[isobenzofuran-1(3H), 4'-piperidin]-1-yl)propyl]acetamide, used for preventing or treating cardiovascular, nervous, metabolic, reproductive, respiratory and/or digestive system disorders |
| 05/18/2006 | US20060106035 Phenyl-substituted pyrazolopyrimidines |
| 05/18/2006 | US20060106019 Novel substituted pyrazolo[1,5 a]-1,3,5-triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same |
| 05/18/2006 | US20060105987 Sulfur-containing phospholipid derivatives |
| 05/18/2006 | US20060105982 Non-invasive gene targeting to ocular cells |
| 05/18/2006 | US20060105966 Novel anticonvulsant derivative salts |
| 05/18/2006 | US20060105957 Loop peptide and TGFalpha for stimulating stem cell proliferation and migration |
| 05/18/2006 | US20060105946 Method for treating the central nervous system by administration of igf structural analogs |
| 05/18/2006 | US20060105059 Fruit and/or vegetable derived composition |
| 05/18/2006 | US20060105046 Polymer conjugates of opioid antagonists |
| 05/18/2006 | DE102005048695A1 Preparation of aripiprazole useful to prepare 7-(4-halobutoxy)-3,4-dihydro-(1H)-quinolinone comprises reacting 7-hydroxy-3,4-dihydro-2(1H)-quinolinone with 1,4-disubstuted-butane followed by reacting with 1-(2,3-dichlorophenyl)piperazine |
| 05/18/2006 | DE102005048694A1 Preparation of 7-hydroxy-3,4-dihydroquinolinone useful as an intermediate in preparing aripiprazole for treating schizophrenia involves reacting N-(3-methoxyphenyl)-3-chloropropionamide with Lewis acid |
| 05/18/2006 | DE102004054634A1 Azaindolcarboxamide Azaindolcarboxamide |
| 05/18/2006 | CA2588073A1 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands |
| 05/18/2006 | CA2587826A1 Azabenzoxazoles for the treatment of cns disorders |
| 05/18/2006 | CA2587667A1 Imine compound |
| 05/18/2006 | CA2587620A1 Tricyclic guanidine derivatives as sodium-proton exchange inhibitors |
| 05/18/2006 | CA2587461A1 Azabenzoxazoles for the treatment of cns disorders |
| 05/18/2006 | CA2586623A1 Process for preparing quinoline compounds and products obtained therefrom |
| 05/18/2006 | CA2586459A1 Therapeutic agent for interstitial cystitis |
| 05/18/2006 | CA2586370A1 Constrained compounds as cgrp-receptor antagonists |
| 05/18/2006 | CA2586124A1 Formulations of [1,4]diazepino[6,7,1-ij]quinoline derivatives |
| 05/18/2006 | CA2585983A1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases |
| 05/17/2006 | EP1657954A1 Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone |
| 05/17/2006 | EP1657247A1 Steroidal compounds for inhibiting steroid sulphotase |
| 05/17/2006 | EP1657242A1 Imidazopyridine derivatives |
| 05/17/2006 | EP1657238A1 Fused pyrimidine derivative and use thereof |
| 05/17/2006 | EP1656940A1 Angiotensin II receptor antagonists for treating vascular headache conditions |
| 05/17/2006 | EP1656938A1 Combinations of SSRI and estrogenic agents |
| 05/17/2006 | EP1656937A1 The use of mirtazapine for the treatment of sleep disorders |
| 05/17/2006 | EP1656936A1 Macrophage activation inhibitor |
| 05/17/2006 | EP1656375A1 Novel quinuclidine derivatives and their pharmaceutical use |
| 05/17/2006 | EP1656361A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 05/17/2006 | EP1656359A2 Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/17/2006 | EP1656358A2 Stable polymorph of bifeprunox mesilate |
| 05/17/2006 | EP1656354A1 Tetrahydroquinazoline derivatives as cfr antagonists |
| 05/17/2006 | EP1656353A1 Gabanergic modulators |
| 05/17/2006 | EP1656352A1 6-(2,2,2-TRIFLUOROETHYLAMINO)-7-CHLORO-2,3,4,5-TETRAHYDRO-1H-BENZO d AZEPINE AS A 5-HT sb 2c /sb RECEPTOR AGONIST |
| 05/17/2006 | EP1656349A1 Cyclopropyl derivatives as nk3 receptor antagonists |
| 05/17/2006 | EP1656151A1 Effects of sporoderm-broken germination activated ganoderma spores on treatment of spinal cord injury and proliferation and/or differentiation of neural stem cells in injured spinal cord |
| 05/17/2006 | EP1656145A1 Spiro-substituted tetrahydroquinazolines as corticotropin releasing factor (cfr) antagonists |
| 05/17/2006 | EP1656141A1 Treatment for alzheimer s disease and related conditions |
| 05/17/2006 | EP1656123A2 Anti-candida agents for the treatment of prion diseases |
| 05/17/2006 | EP1656122A1 Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease |
| 05/17/2006 | EP1656112A1 Buccal formulations of galanthamine and uses thereof |
| 05/17/2006 | EP1558252A4 Substituted furo 2,3-b| pyridine derivatives |
| 05/17/2006 | EP1551821B1 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia |
| 05/17/2006 | EP1543003B1 Imidazo¬1,2-a|pyridines |